Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines, vaccines franchises, support, and corporate functions 1973 and is headquartered in Paris, France. 

CEO
Belén Garijo López
CEOBelén Garijo López
Employees
76,493
Employees76,493
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1973
Founded1973
Employees
76,493
Employees76,493

SNY Key Statistics

Market cap
102.01B
Market cap102.01B
Price-Earnings ratio
21.48
Price-Earnings ratio21.48
Dividend yield
4.21%
Dividend yield4.21%
Average volume
3.66M
Average volume3.66M
High today
$42.28
High today$42.28
Low today
$41.63
Low today$41.63
Open price
$41.83
Open price$41.83
Volume
2.91M
Volume2.91M
52 Week high
$52.68
52 Week high$52.68
52 Week low
$39.07
52 Week low$39.07

SNY News

Simply Wall St 17h
Why Recursion Pharmaceuticals Stock Is Up 6.6% And What's Next

Recursion Pharmaceuticals reported that Sanofi has optioned the first development candidate from their AI-driven collaboration, triggering a US$10 million miles...

Financial Times 2d
Can French drugmaker Sanofi fix its pipeline? - Financial Times

...

Can French drugmaker Sanofi fix its pipeline? - Financial Times
24/7 Wall St. 2d
Regeneron's Billion-Dollar Catalyst Flying Under Wall Street’s Radar Ahead of Oct. 30 Earnings

Investing Regeneron’s Billion-Dollar Catalyst Flying Under Wall Street’s Radar Ahead of Oct. 30 Earnings Regeneron (NASDAQ:REGN | REGN Price Prediction) reports...

Regeneron's Billion-Dollar Catalyst Flying Under Wall Street’s Radar Ahead of Oct. 30 Earnings

Analyst ratings

50%

of 10 ratings
Buy
50%
Hold
50%
Sell
0%

More SNY News

TipRanks 5d
Sanofi’s New Oral Alzheimer’s Drug Enters Mid-Stage Trials: What Investors Should Watch

Sanofi SA (SNY) announced an update on their ongoing clinical study. Sanofi is running a mid-stage study called “A Phase 2, Randomized, Double-blind, Placebo-c...

TipRanks 5d
Sanofi Advances Rilzabrutinib Kidney Study, Supporting Long-Term BTK Pipeline Potential

Sanofi SA (SNY) announced an update on their ongoing clinical study. The Phase 1 study “An Open-label, Multi-center, Phase 1 Pharmacokinetic and Tolerability S...

TipRanks 6d
Sanofi Shuts Down Long-Term IBD Drug Study, Nudging Expectations for Future Growth

Sanofi (SNYNF) announced an update on their ongoing clinical study. Sanofi has ended a multinational extension study called SPECIFI-IBD-LTS, which tracked long...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.